1. Evaluation of efficacy and safety for recombinant human adenovirus-p53 in the control of the malignant pleural effusions via thoracic perfusion
    Rong Biaoxue et al, 2016, Sci Rep CrossRef
  2. Time-staggered inhibition of JNK effectively sensitizes chemoresistant ovarian cancer cells to cisplatin and paclitaxel
    MANABU SEINO et al, 2016 CrossRef
  3. Potential role of targeted therapies in the treatment of triple-negative breast cancer
    Lee Yueh Jia et al, 2016, Anti-Cancer Drugs CrossRef
  4. Juglanin inhibits lung cancer by regulation of apoptosis, ROS and autophagy induction
    Liang Chen et al, 2017, Oncotarget CrossRef
  5. Targeting Different Pathways Using Novel Combination Therapy in Triple Negative Breast Cancer
    Manzoor A. Mir et al, 2020, CCDT CrossRef
  6. Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer
    Kyu Sic You et al, 2021, Pharmaceuticals CrossRef
  7. RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast Cancer.
    Siang-Boon Koh et al, 2021, Clin Cancer Res CrossRef
  8. E3 ubiquitin ligase RNF180 reduces sensitivity of triple-negative breast cancer cells to Gefitinib by downregulating RAD51
    Pian Liu et al, 2022, Chemico-Biological Interactions CrossRef
  9. Eucommia ulmoides Oliver-Tribulus terrestris L. Drug Pair Regulates Ferroptosis by Mediating the Neurovascular-Related Ligand-Receptor Interaction Pathway- A Potential Drug Pair for Treatment Hypertension and Prevention Ischemic Stroke
    Qian Zhang et al, 2022, Front. Neurol. CrossRef
  10. Anti-CD44 and EGFR Dual-Targeted Solid Lipid Nanoparticles for Delivery of Doxorubicin to Triple-Negative Breast Cancer Cell Line: Preparation, Statistical Optimization, and In Vitro Characterization
    Farnosh Darabi et al, 2022, BioMed Research International CrossRef
  11. Raloxifene potentiates the effect of gefitinib in triple-negative breast cancer cell lines
    Sebastien Taurin et al, 2022, Med Oncol CrossRef
  12. Regression of Human Breast Carcinoma in Nude Mice after Adsflt Gene Therapy Is Mediated by Tumor Vascular Endothelial Cell Apoptosis
    Angelina Felici et al, 2022, Cancers CrossRef
  13. A recombinant adenovirus vector containing the synNotch receptor gene for the treatment of triple-negative breast cancer
    Ruhan A et al, 2023, Front. Oncol. CrossRef
  14. Oncolytic virus-based combination therapy in breast cancer
    Amirhossein Bahreyni et al, 2024, Cancer Letters CrossRef
  15. Cancer biotherapy: review and prospect
    Qi Liu et al, 2024, Clin Exp Med CrossRef